TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+17.03%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$348M
AUM Growth
+$348M
(+17%)
Cap. Flow
+$7.1M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
68.53%
Holding
34
New
2
Increased
17
Reduced
5
Closed
3
Top Buys
| 1 |
Labcorp
LH
|
$9.9M |
| 2 |
Hologic
HOLX
|
$7.17M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$7.04M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$6.18M |
| 5 |
Glaukos
GKOS
|
$4.87M |
Top Sells
| 1 |
NovoCure
NVCR
|
$24.5M |
| 2 |
Dentsply Sirona
XRAY
|
$12M |
| 3 |
Medtronic
MDT
|
$6.3M |
| 4 |
VSI
Vitamin Shoppe Inc.
VSI
|
$3.25M |
| 5 |
SIEN
Sientra, Inc.
SIEN
|
$2.44M |
Sector Composition
| 1 | Healthcare | 88.87% |
| 2 | Industrials | 6.24% |
| 3 | Consumer Discretionary | 2.72% |
| 4 | Communication Services | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
1
DELISTED
NuVasive, Inc.
NUVA
| $37.4M | 10.68% | 525,000 +25,000 | +5% | +$1.78M |
|
|
2
NovoCure
NVCR
$1.38B
| $33.4M | 9.54% | 635,000 -465,000 | -42% | -$24.5M |
|
|
3
Labcorp
LH
$23.1B
| $27.8M | 7.93% | 160,000 +57,000 | +55% | +$9.9M |
|
|
MDRX
4
DELISTED
Veradigm Inc. Common Stock
MDRX
| $26.4M | 7.55% | 1,950,000 +350,000 | +22% | +$4.75M |
|
|
5
Medtronic
MDT
$119B
| $25.6M | 7.3% | 260,000 -64,000 | -20% | -$6.3M |
|
|
SRCL
6
DELISTED
Stericycle Inc
SRCL
| $21.7M | 6.2% | 370,000 +120,000 | +48% | +$7.04M |
|
7
Bio-Rad Laboratories Class A
BIO
$8.06B
| $20.3M | 5.81% | 65,000 +10,000 | +18% | +$3.13M |
|
|
NXTM
8
DELISTED
NxStage Medical Inc.
NXTM
| $16.7M | 4.78% | 600,000 +129,463 | +28% | +$3.61M |
|
|
9
Rigel Pharmaceuticals
RIGL
$697M
| $14.6M | 4.17% | 4,550,000 +1,925,000 | +73% | +$6.18M |
|
10
Lantheus
LNTH
$3.73B
| $14.5M | 4.14% | 970,000 +185,381 | +24% | +$2.77M |
|
|
11
Hologic
HOLX
$14.9B
| $14.3M | 4.1% | 350,000 +175,000 | +100% | +$7.17M |
|
|
CORI
12
DELISTED
Corium International, Inc.
CORI
| $13.6M | 3.87% | 1,425,000 +60,721 | +4% | +$577K |
|
13
Gilead Sciences
GILD
$140B
| $13.5M | 3.86% | 175,000 -25,000 | -13% | -$1.93M |
|
|
OPTN
14
DELISTED
OptiNose
OPTN
| $10.7M | 3.05% | 860,000 +235,000 | +38% | +$2.92M |
|
15
AtriCure
ATRC
$1.84B
| $9.63M | 2.75% | 275,000 +15,000 | +6% | +$525K |
|
16
Service Corp International
SCI
$11.1B
| $9.45M | 2.7% | 213,856 +20,330 | +11% | +$899K |
|
|
CORV
17
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $8.28M | 2.36% | 2,060,000 +60,000 | +3% | +$241K |
|
18
Pacira BioSciences
PCRX
$1.2B
| $7.37M | 2.11% | 150,000 -40,000 | -21% | -$1.97M |
|
|
VSI
19
DELISTED
Vitamin Shoppe Inc.
VSI
| $6M | 1.71% | 600,000 -325,000 | -35% | -$3.25M |
|
|
HIND
20
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $5.67M | 1.62% | 2,100,000 +1,050,000 | +100% | +$2.84M |
|
|
21
Glaukos
GKOS
$5.5B
| $4.87M | 1.39% | +75,000 | New | +$4.87M |
|
|
ISEE
22
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.36M | 0.67% | 1,000,000 +75,000 | +8% | +$177K |
|
|
STRM
23
DELISTED
Streamline Health Solutions
STRM
| $2.24M | 0.64% | 1,900,000 +727,709 | +62% | +$859K |
|
|
MODN
24
DELISTED
MODEL N, INC.
MODN
| $1.59M | 0.45% | +100,000 | New | +$1.59M |
|
25
Alkermes
ALKS
$4.78B
| – | – | 0 | – | – |
|